InayofuataMwongozo unaofuata
AI katika Roboti za Ghala
Viwanda
MWONGOZO wa Viwanda
Surgical robotics includes surgeon-controlled robotic-assisted systems and research on more autonomous tasks.
Sikiliza mwongozo huuInaonyeshwa na AI · ~2 min
AI methods may process images or assist planning, but clinical capability depends on the specific device and study.
The da Vinci system is described by its manufacturer as surgeon-controlled robotic assistance. The STAR paper demonstrated supervised autonomous suturing of soft bowel tissue in animal models and describes stereo imaging, tissue-landmark detection and suture planning. The AVOID randomized phase 3 trial used ICG near-infrared fluorescence to assess bowel perfusion and adjust transection lines; its overall 90-day leakage rate was not significantly lower than conventional assessment. These examples do not establish universal autonomy or clinical benefit. In deformable-tissue surgery, tissue movement and visual constraints such as occlusion challenge image-based planning. The AVOID trial’s primary endpoint was clinically relevant anastomotic leakage within 90 days and showed no significant overall reduction with ICG fluorescence. The STAR animal study reports comparative consistency on specific measures including suture spacing and bite depth; it does not establish universal clinical superiority.
Intuitive describes da Vinci as a surgeon-controlled robotic-assisted system operated from a console.
The STAR research robot demonstrated supervised suturing of soft bowel tissue in animal models.
The STAR paper describes stereo imaging and tissue-landmark detection in its planning pipeline.
A randomized AVOID trial studied ICG near-infrared fluorescence for assessing bowel perfusion during colorectal surgery.
Research may test additional sensing and planning methods, but claims about clinical benefit, autonomy or regulatory expectations need evidence from a named device, study and jurisdiction. Preserving clinician oversight is presented here as a design recommendation.
Jarida halali
Hadithi tatu za AI zilizothibitishwa kila asubuhi ya wiki, zimetengenezwa kwa Kiingereza rahisi. Bila malipo daima, hakuna matangazo.
Barua pepe moja kila siku ya wiki. Jiondoe kwa bonyeza moja. Hatutauza au kushiriki anwani yako.
Jijaribu mwenyewe
Maoni ya haraka juu ya kila jibu, na cheti kinachoweza kushirikishwa na kitambulisho kinachoweza kuthibitishwa baada ya kupita kozi.
Changia elimu ya AI bila malipo. AI Understanding ni 501(c)(3) isiyo na faida — hakuna matangazo, hakuna kizuizi cha malipo, daima. Toa mchango
Surgical robotics includes surgeon-controlled robotic-assisted systems and research on more autonomous tasks. AI methods may process images or assist planning, but clinical capability depends on the specific device and study.
Intuitive describes da Vinci as a surgeon-controlled robotic-assisted system. This is a manufacturer-described capability, not a prevalence claim.
Roboti ya Smart Tissue Autonomous (STAR) iliunganisha kwa uhuru tishu za utumbo zinazoweza kuharibika katika nguruwe, na kutoa mishono inayofanana zaidi kuliko madaktari bingwa wa upasuaji wa binadamu katika onyesho muhimu la uhuru unaosimamiwa.
Tofauti na sehemu ngumu za kiwandani, tishu za upasuaji hubadilika kila mara umbo na huwa mvua, huakisi, na mara kwa mara hufichwa na kutokwa na damu, moshi wa pazia, na vyombo, na kufanya ugawaji na ufuatiliaji wa kuaminika kuwa mgumu.
The AVOID phase 3 trial reported no significant difference in overall 90-day clinically relevant leakage between fluorescence-guided and conventional groups. This is a study result, not a conclusion about every procedure or subgroup.
The randomized AVOID trial used ICG fluorescence to assess bowel perfusion and adjust or keep transection lines. It did not significantly reduce the overall 90-day leak rate in the studied population.
Endelea kujifunza
Miongozo zaidi imechaguliwa kwa mada hii
InayofuataMwongozo unaofuata
AI katika Roboti za Ghala
Viwanda